Valirx (VAL)

 

VAL Share PerformanceMore

52 week high17.2999 16/05/16
52 week low2.3100 22/03/17
52 week change -7.0000 (-73.68%)
4 week volume60,812,203 27/02/17

Media for (VAL)

Presenter: ValiRx Management Team
08/03/2017
Presenter: Suzanne Dilly
01/12/2016

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Director Deals - ValiRx PLC (VAL)

Satu Vainikka, Chief Executive Officer, bought 400,000 shares in the company on the 15th March 2017 at a price of 2.50p. T...

Director Deals - ValiRx PLC (VAL)

Satu Vainikka, Chief Executive Officer, bought 400,000 shares in the company on the 15th March 2017 at a price of 2.50p. T...

Director Deals - ValiRx PLC (VAL)

Satu Vainikka, Chief Executive Officer, bought 400,000 shares in the company on the 15th March 2017 at a price of 2.50p. T...

Director/PDMR Shareholding

RNS Number: 5388Z ValiRx PLC 15 March 2017 ValiRx Plc ("ValiRx" or "the Company") PDMR / Director Dealing London, UK., 15 March 2017: ValiRx Plc (AIM: VAL), a clinical stage biotechnology company, announces that it has received the following notifications from PDMRs of dealings in the Company's shares, all of which related to the issue of shares annou...

ValiSeek Clinical Development Update

RNS Number: 7842Y ValiRx PLC 08 March 2017 ValiRx Plc ("ValiRx" or "the Company") VALISEEK CLINICAL DEVELOPMENT UPDATE London, UK ., 8 March 2017: ValiRx Plc (AIM: VAL), a clinical stage biotechnology company, is pleased to provide an update on the clinical development of the joint venture between ValiRx and Tangent Reprofiling Limite...

ValiRX - Projects update

Director Deals - ValiRx PLC (VAL)

Satu Vainikka, Chief Executive Officer, 400,000 shares in the company on the 1st March 2017 at a price of 2.50p. The Direc...

Director Deals - ValiRx PLC (VAL)

Satu Vainikka, Chief Executive Officer, 400,000 shares in the company on the 1st March 2017 at a price of 2.50p. The Direc...

Fundamental DataMore

EPS-6.66
Dividend yield0 %

Equity Research (VAL)

edison investment research
ValiRx plc
20/01/2015
V22 is an enterprise that showcases the wealth of talent in contemporary art. It has built a broad portfolio of around 150 artworks of living artists from around the world, paying in a mix of cash...

Latest discussion posts More

Users' HoldingsMore

Users who hold Valirx also hold..
ROCKHOPPER18%
RANGE RES.17%
LLOYDS GRP.17%
SOUND ENERGY17%
SAREUM15%

Codes & Symbols

ISINGB00BWWYSP41
SymbolsVAL, LSE:VAL, VAL.L, VAL:LN, LON:VAL, XLON:VAL